(Q42102014)

16 October 2017

Growth in children treated for acute lymphoblastic leukaemia (English)

1 reference

16 October 2017

1 reference

1

1 reference

16 October 2017

S M Shalet

2

1 reference

16 October 2017

P H Morris-Jones

series ordinal

3

1 reference

16 October 2017

D A Price

series ordinal

4

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 February 1988

1 reference

16 October 2017

1 reference

16 October 2017

1

1 reference

16 October 2017

460-462

1 reference

16 October 2017

8583

1 reference

Height of children successfully treated for acute lymphoblastic leukemia: a report from the Late Effects Study Committee of Childrens Cancer Study Group.

16 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991246-9

7 January 2021

Normal growth despite abnormalities of growthhormone secretion in children treated for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991246-9

7 January 2021

Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991246-9

7 January 2021

Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991246-9

7 January 2021

Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991246-9

7 January 2021

Growth effects of long-term antileukemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991246-9

7 January 2021

10.1016/S0140-6736(88)91246-9

Identifiers

DOI

1 reference

16 October 2017

1 reference